diclofenac has been researched along with B16 Melanoma in 2 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sato, K | 1 |
| Takahashi, H | 1 |
| Toriyama, M | 1 |
| Liu, LY | 1 |
| Hu, CL | 1 |
| Ma, LJ | 1 |
| Zhang, ZH | 1 |
| Mei, YA | 1 |
2 other studies available for diclofenac and B16 Melanoma
| Article | Year |
|---|---|
Depigmenting mechanism of NSAIDs on B16F1 melanoma cells.
Topics: alpha-MSH; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Humans; Intramolecular Oxid | 2011 |
ET-1 inhibits B-16 murine melanoma cell migration by decreasing K(+) currents.
Topics: Animals; Cell Movement; Diclofenac; Endothelin-1; Melanoma, Experimental; Mice; Potassium; Potassium | 2004 |